Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ototoxicity: therapeutic opportunities.

Leonard P Rybak1, Craig A Whitworth

  • 1Department of Surgery, Southern Illinois University, School of Medicine, P.O. Box 19653, Springfield, IL 62794-9653, USA. lrybak@siumed.edu

Drug Discovery Today
|October 11, 2005
PubMed
Summary

Aminoglycoside antibiotics and platinum chemotherapy cause hearing loss by damaging inner ear hair cells. Antioxidant strategies aim to protect against this ototoxicity, but drug delivery and efficacy remain challenges.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cochlear amyloid beta 42-mediated hearing loss: A marker of preclinical Alzheimer's disease.

Neural regeneration research·2026
Same author

Cochlear Amyloid-β42 Accumulation Drives Progressive Auditory Neuropathy in 5XFAD Mice: A Potential Biomarker for Early Alzheimer's Disease.

Research square·2025
Same author

Role of RGS17 in cisplatin-induced cochlear inflammation and ototoxicity via caspase-3 activation.

Frontiers in immunology·2025
Same author

Effects of natural products on cisplatin ototoxicity and chemotherapeutic efficacy.

Expert opinion on drug metabolism & toxicology·2023
Same author

Targeting CXCL1 chemokine signaling for treating cisplatin ototoxicity.

Frontiers in immunology·2023
Same author

Oxidative Stress and Inflammation Caused by Cisplatin Ototoxicity.

Antioxidants (Basel, Switzerland)·2021

Area of Science:

  • Ototoxicity research
  • Pharmacology
  • Cell biology

Background:

  • Aminoglycoside antibiotics and platinum-based chemotherapy are crucial drugs with ototoxicity as a significant side effect.
  • These drugs damage cochlear hair cells, leading to permanent hearing loss.
  • Reactive oxygen species (ROS) are implicated in the cell-death pathways activated by these drugs.

Purpose of the Study:

  • To explore strategies for preventing drug-induced hearing loss (ototoxicity).
  • To investigate the role of reactive oxygen species in ototoxicity.
  • To evaluate antioxidant and anti-apoptotic approaches for inner ear protection.

Main Methods:

  • Review of existing literature on ototoxicity mechanisms.
  • Analysis of antioxidant and downstream apoptosis inhibition strategies.

Related Experiment Videos

  • Discussion of drug delivery challenges to the inner ear.

    • Main Results:

    • Ototoxicity is mediated by reactive oxygen species, triggering cell-death cascades.
    • Antioxidant administration offers upstream protection against ototoxicity.
    • Downstream interruption of apoptosis can prevent further cell death.

    Conclusions:

    • Protecting the inner ear from ototoxicity requires addressing reactive oxygen species and cell-death pathways.
    • Effective drug delivery to the cochlea is critical for therapeutic success.
    • Balancing ototoxicity prevention with the efficacy of essential antibiotics and chemotherapeutics is a key challenge.